US20060100693A1 - Multi-property nitinol by heart treatment - Google Patents
Multi-property nitinol by heart treatment Download PDFInfo
- Publication number
- US20060100693A1 US20060100693A1 US11/314,114 US31411405A US2006100693A1 US 20060100693 A1 US20060100693 A1 US 20060100693A1 US 31411405 A US31411405 A US 31411405A US 2006100693 A1 US2006100693 A1 US 2006100693A1
- Authority
- US
- United States
- Prior art keywords
- shape
- guidewire
- memory
- stent
- treated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/01—Filters implantable into blood vessels
- A61F2/0105—Open ended, i.e. legs gathered only at one side
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/01—Filters implantable into blood vessels
- A61F2002/016—Filters implantable into blood vessels made from wire-like elements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
- A61F2002/91533—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other characterised by the phase between adjacent bands
- A61F2002/91541—Adjacent bands are arranged out of phase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
- A61F2002/9155—Adjacent bands being connected to each other
- A61F2002/91558—Adjacent bands being connected to each other connected peak to peak
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0002—Two-dimensional shapes, e.g. cross-sections
- A61F2230/0028—Shapes in the form of latin or greek characters
- A61F2230/005—Rosette-shaped, e.g. star-shaped
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0063—Three-dimensional shapes
- A61F2230/0069—Three-dimensional shapes cylindrical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0063—Three-dimensional shapes
- A61F2230/0073—Quadric-shaped
- A61F2230/008—Quadric-shaped paraboloidal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0014—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
- A61F2250/0018—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in elasticity, stiffness or compressibility
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0014—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
- A61F2250/0042—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in shape-memory transition temperatures, e.g. in martensitic transition temperature, in austenitic transition temperature
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0014—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
- A61F2250/0048—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in mechanical expandability, e.g. in mechanical, self- or balloon expandability
Definitions
- the present invention is related to the use of shape memory materials in medical devices.
- a shape memory material can assume an initial high temperature configuration and a deformed low temperature configuration and revert back to the initial high temperature configuration upon the application of heat.
- the high temperature configuration of the material is set into the material or memorized during an initial shaping step in which the material is maintained at a high temperature in a desired shape for a period of time.
- This shape memory exhibited by metals results from the metal undergoing a reversible solid state phase transition. Specifically, the metal transitions from an austenitic state to a martensitic state with a decrease in temperature.
- the temperature at which the transition begins is typically designated M s (martensite start temperature) while the temperature at which the transition finishes is designated M f (martensite finish temperature).
- M s martensite start temperature
- M f martensite finish temperature
- a s Austenitic start temperature
- a f Austenitic finish temperature
- Shape-memory materials have been disclosed in U.S. Pat. No. 3,012,882 to Muldawer et al. and U.S. Pat. No. 3,174,851 to Buehler et al. both of which are incorporated herein by reference in their entirety.
- Nitinol stents which are fully expanded in the austenitic state and compressed or partially expanded in the martensitic state have been disclosed.
- the specific Nitinol alloy is chosen such that the stent will be in the austenitic state at body temperature.
- the stent Prior to insertion into the body, the stent is maintained at low temperature corresponding to a temperature within the martensitic range.
- the stent is warmed to at least the A f temperature and in the process expanded to its desired final diameter.
- Shape-memory metals have been disclosed for use in other medical devices as well.
- the physical properties, including elasticity and stiffness, of a shape-memory metal may be controlled via a variety of factors including the chemical composition of the alloy and the treatment to which the alloy is subjected.
- Commonly assigned U.S. patent application Ser. No. 09/008684 incorporated herein in its entirety by reference, discloses a process for improving the ductility of Nitinol via control of a number of process parameters.
- the physical properties of a shape-memory material may also be controlled by heat treating the material. By selective local heat treatment of a shape-memory material, it is possible to destroy the austenitic-martensitic transition and/or change the elasticity and stiffness.
- the present invention is directed to medical devices which use shape-memory materials that have been differentially heat treated to exhibit spatially varying properties such as elasticity and stiffness.
- the present invention is directed to medical devices having been formed, at least in part, from shape-memory materials which have been locally treated to alter their memory characteristics relative to portions of the device which have not been subjected to the local heat treatment. Specifically, a region of the shape-memory material is treated to decrease the stiffness of the region relative to the remainder of the medical device. Desirably, the local treatment will destroy the superelastic properties of the locally treated region.
- the invention is directed in particular to a stent having been formed at least in part of a shape-memory material.
- the stent comprises a plurality of cells arranged in columns extending from one end of the stent to the other. Adjacent columns of cells are interconnected.
- the stent includes at least one differently treated column of cells which has been treated differently from the remainder of the stent to have different shape-memory properties from the remainder of the stent.
- the invention is also directed to a stent wherein at least one of the columns is characterized by a reduced elasticity relative to the remainder of the columns.
- the invention is also directed to a stent wherein at least one of the columns is characterized by a reduced stiffness relative to the remainder of the columns.
- the invention is further directed to a stent wherein at a desired temperature range, at least one longitudinal column of cells does not have superelastic properties while the remainder of the longitudinal columns do have superelastic properties.
- the invention is also directed to a stent having been formed of a shape memory material and comprising a plurality of spaced segments. Adjacent spaced segments are connected to each other by one or more connector sections. Each segment comprises a series of interconnected cells. Desirably, the cells in plan view are of polygonal configuration. The segments have been subjected to a different heat treatment than the connector sections.
- the invention is also directed to a stent having been formed of a shape memory material and comprising a plurality of spaced segments with adjacent spaced segments connected to each other by one or more connector sections.
- Each segment comprises a series of interconnected cells.
- the cells in plan view are of polygonal configuration.
- the segments have a reduced stiffness relative to the connector sections.
- the segments are not superelastic.
- the invention is directed to a medical guidewire having been formed at least in part of a shape-memory metal. Different portions of the shape-memory metal have been treated differently to have different shape-memory properties. Desirably, at least one portion of the guidewire is subjected to a local heat treatment resulting in a reduced stiffness compared with the remainder of the guidewire. In this way, a guidewire of desired flexibility can be prepared. Via the localized heat treatment, a guidewire may be prepared in which at least a portion thereof retains its shape memory properties while a portion thereof loses its shape memory properties.
- the invention is directed to implantable medical filters such as vena cava filter having been formed of shape-memory materials. At least a portion of the shape-memory material is differently treated to alter the shape-memory properties of the material relative to the untreated shape-memory material. Desirably, the differently treated portion will be heat treated and exhibit a greater tendency toward plastic deformation relative to the remainder of the filter.
- FIG. 1 illustrates the stress-strain behavior of an alloy which can undergo a transition from a martensitic state to an austenitic state and the stress-strain behavior of the alloy following additional heat treatment.
- FIG. 2 illustrates the stress-strain behavior of an alloy which can undergo a transition from a martensitic state to an austenitic state and the stress-strain behavior of the alloy following additional heat treatment.
- FIG. 3 a is a side-elevational view of a stent made in accordance with the present invention.
- FIG. 3 b is a side-elevational view of the stent of FIG. 3 in which the treated column of cells has not been fully expanded.
- FIG. 4 a is a side elevational view of a stent made in accordance with the present invention.
- FIG. 4 b is a side elevational view of the stent of FIG. 4 a after it has been bent.
- FIGS. 5 a and 5 b are views of embodiments of the invention in which connecting segments have been treated.
- FIG. 6 a shows a side elevational view of an inventive guidewire.
- FIG. 6 b shows the guidewire of FIG. 6 a in a bent configuration.
- FIG. 6 c shows the guidewire of FIG. 6 b after it has been released from the bent configuration.
- FIG. 6 d shows a side elevational view of an inventive guidewire whose distal tip has been treated to exhibit a reduced stiffness.
- FIG. 7 a shows a side elevational view of a prior art guidewire.
- FIG. 7 b shows the guidewire of FIG. 7 a in a bent configuration.
- FIG. 7 c shows the guidewire of FIG. 7 b after it has been released from the bent configuration.
- FIG. 8 shows a side elevational view of an inventive vena cava filter.
- the present invention is directed to the selective treatment of portions of a medical device containing a shape memory material. More specifically, the invention is directed to differential treatment of the shape memory material in a medical device to achieve different physical properties in different portions of the device.
- Shape memory characteristics of the material may be altered by heat treating the material.
- heat treating portions of a shape-memory metal it is possible to produce a metal with spatial variations in the elasticity and stiffness of the metal.
- the locally treated portions will initiate plastic deformation at a lower strain than the portions that have not been locally treated.
- the material may simply have a reduced stiffness in the locally treated portion or the superelasticity of the locally treated portion may be destroyed with the locally treated portion being plastically deformable.
- FIG. 1 a stress-strain curve (solid line) is shown for a shape-memory material.
- the stress-strain curve (dashed line) for the same material following additional heat treatment of the material is also shown.
- the material has a reduced load and unload plateau, as shown in FIG. 1 and the material initiates plastic deformation at a lower strain level.
- FIG. 2 the stress-strain curve (solid line) is shown for a shape-memory material.
- the stress-strain curve (dashed line) for the same material following significant additional heat treatment to eliminate the superelastic properties of the material is also shown in FIG. 2 .
- the shape memory material based medical device is typically subject to a first annealing using standard annealing processing conditions as are known in the art. Desirably, the device will be annealed for about 5 minutes to about 40 minutes at a temperature ranging from about 400 C to about 575 C. More desirably, the device will be annealed for about 10 minutes to about 15 minutes. Also more desirably, the device will be annealed at a temperature ranging from about 450 C to about 550 C. Shorter or longer periods may be used as may higher or lower temperatures, depending on the material being annealed and the desired properties of the material.
- the localized heat treatment of the desired shape-memory material medical device may be accomplished by any suitable method.
- One such suitable method involves the use of electrical resistance heating. Electrical leads are attached across the desired portion of the device and a current allowed to pass therethrough. Because of the resistance of the shape-memory metal, the desired portion of metal heats up thereby further annealing the material.
- the technique has been applied to a stent made of Nitinol wire (0.014 inch diameter). Leads were attached to a desired portion of the stent and 4 Volts applied to the wire. After 20 seconds, the desired portion of the wire transitioned from a superelastic state to a plastic state.
- Another suitable method involves applying a heated inert gas jet to a desired portion of the medical device to selectively heat a desired portion of the device.
- Yet another method involves the use of an induction coil.
- An induction coil may be placed over a desired portion of the medical device to effect induction heating of the desired portion of the medical device.
- a laser may also be used to selectively heat desired regions of the medical device.
- the desired regions of the medical device may also be brazed.
- the medical device may also be placed in a heat treating fluid such as a salt bath or a fluidized sand bath with appropriate sections of the device insulated.
- the second annealing step is typically carried out at a temperature of about 550 C to about 600 C for about five minutes to about 20 minutes. At such temperatures, the stiffness of the material will be reduced. As with the first annealing step, the exact time and temperature of the second annealing step depends on the material chosen (i.e. its composition) and on the form of the material (for example, in wire form or in sheet form). In certain cases, it may be desirable for the second annealing step to be carried out over shorter or longer periods of time and at lower or higher temperatures than those disclosed above.
- the invention contemplates localized heat treating of a variety of medical devices including stents, medical guidewires and filters such as vena cava filters.
- stent is intended to include a variety of related devices including stents, grafts and stent-grafts in particular and endoluminal prostheses in general.
- the invention is directed to a stent, shown generally at 100 , comprised of a plurality of cells 104 arranged in columns 108 extending from one end 112 of the stent to the other end 116 . Adjacent columns 108 of cells 104 are interconnected.
- the stent includes at least one differently treated column 108 a of cells 104 a which has been treated differently from the remainder of columns 108 b to have different shape-memory properties from the remainder of the stent.
- differently treated column 108 a will be characterized by an increased tendency to plastic deformation relative to the remainder of the stent and will be plastically deformable. More desirably, the superelasticity of the differently treated portion will be destroyed as a result of the heat treatment.
- the invention also contemplates treating the column(s) such that the treated portion loses its shape memory characteristic.
- FIG. 3 b shows the stent of FIG. 3 a in a partially expanded state.
- Untreated columns 108 b are shown in an expanded state, having been exposed to a sufficient temperature to cause the metal to transition to its austenitic state.
- Treated column 108 a is in an unexpanded state, the superelastic properties of the material having been locally destroyed.
- stent 100 may be further expanded by applying a radially outward force to the stent thereby opening or expanding treated column(s) 108 a.
- a balloon catheter or other expansion device may be used to effect such a ‘touch-up’ expansion of the stent.
- the stent may later be ‘touched up’ via mechanical expansion of the cells of the treated column to better fit in a lumen.
- FIGS. 4 a and 4 b Another stent formed in accordance with the present invention is shown generally at 100 in FIGS. 4 a and 4 b.
- One or more circumferential bands of cells 122 is specially treated, in accordance with the invention.
- Bands 122 have different shape memory properties from the cells in the remainder of the stent.
- band(s) 122 may be plastically deformable.
- FIG. 4 a depicts stent 100 prior to being deformed at band 122 while FIG. 4 b depicts stent 100 after it has been bent at band 122 .
- the remainder of the stent which has not been subjected to the special treatment retains the shape memory properties of the material.
- the invention is also directed to the stent shown generally at 100 in FIG. 5 a, comprised of a plurality of spaced segments 120 .
- Each segment 120 is desirably comprised of a series of interconnected cells 124 .
- cells 124 will be of polygonal configuration in plan view. More desirably, they will be hexagonal.
- Adjacent spaced segments 120 are connected to each other by one or more connector sections 128 .
- Connector sections 128 may be disposed at an oblique angle relative to the longitudinal axis 180 of the stent as shown in FIG. 5 a or they may be substantially parallel to the longitudinal axis 180 as shown in FIG. 5 b. They may be straight or curved.
- Segments 120 have been subjected to a local heat treatment, in accordance with the invention. Desirably, segments 120 will be of lower stiffness than connector sections 128 as a result of the heat treatment.
- Stent 100 may be made of any suitable shape-memory material including shape-memory metals such as Nitinol. Nitinol with a composition of about 55.75% (by weight) nickel and 44.25% (by weight) titanium may be particularly well suited for use in the present invention.
- the stent may be made of shape-memory wire or a sheet or tube of shape-memory material.
- the invention is also directed to stents similar to those shown in FIGS. 5 a and 5 b, such as those disclosed in U.S. Ser. No. 08/942162 incorporated herein in its entirety by reference, wherein the connector sections and the segments are subject to different heat treatments.
- FIGS. 3-5 are intended to be exemplary. Stents with other designs may be treated similarly.
- the invention is directed to medical guidewires made of shape-memory materials, portions of which have been differentially treated.
- a medical guidewire such as that shown at 200 in FIG. 6 a, is specially treated toward distal end 204 of the guidewire.
- Region 208 of the device is heat treated to increase the tendency toward plastic deformation of the treated portion relative to the remainder of the guidewire. This, in turn, allows the guidewire to have a region of greater flexibility and a region of reduced flexibility corresponding to the locally treated section of the guidewire.
- FIGS. 6 b and FIG. 6 c illustrate the guidewire of FIG. 6 a as it is bent and released.
- guidewire 200 is bent.
- Region 208 has a greater tendency toward plastic deformation.
- the remainder 212 of guidewire 200 is in the austenitic state and thus deforms elastically.
- the guidewire of FIG. 6 b is shown in FIG. 6 c after it has been released from its bent position.
- Locally treated region 208 remains bent while austenitic regions 212 recovery fully to their configuration prior to being bent.
- Nitinol which has been treated to have spatially varying properties, it is possible to prepare a guidewire which may be permanently deformed within the body.
- a local heat treatment may also be used to reduce the stiffness of the tip of the guidewire prior to inserting the guidewire into the body. This is illustrated schematically in FIG. 6d .
- Distal end 204 of guidewire 200 has been subject to an additional heat treatment to reduce the stiffness of the distal end relative to the remainder of the guidewire. If the superelasticity is completely destroyed, a permanent bend may be placed in the guidewire, thereby allowing a physician to shape a guide wire as desired.
- FIG. 7 a shows guidewire 200 .
- the entire guidewire is in the austenitic state 212 .
- guidewire 200 is shown in a bent configuration.
- a small region 208 is in a stress-induced martensitic state while the remainder 212 of guidewire 200 is in the austenitic phase.
- the entire guidewire Upon release of the guidewire, as shown in FIG. 7 c, the entire guidewire returns to the configuration it had prior to being bent. The entire guidewire is in the austenitic state.
- FIG. 8 shows a vena cava filter generally at 300 .
- Vena cava filter 300 is similar in design to that disclosed in commonly assigned U.S. Pat. No. 5,709,704 to Nott et al., the content of which is incorporated herein in its entirety by reference.
- Filter 300 is constructed, at least in part, of a shape memory material.
- Filter 300 includes a single cell 304 in which the shape-memory material is differentially heat treated to increase the tendency to plastic deformation of the desired portion of the filter.
- FIG. 8 shows an embodiment in which only a single cell has been heat treated differently, the invention contemplates other embodiment in which a plurality of cells has been differently treated.
- One such variant involves a filter comprised of multiple columns of cells, one of the columns having been subjected to a different heat treatment.
- the invention may be practiced generally with shape-memory materials.
- binary shape-memory metals such as Nitinol or other alloys of Nickel and Titanium will be used.
- the invention also contemplates the use of doped binary metals as well. Suitable dopants include Chromium, Niobium and Vanadium. Additional suitable shape-memory alloys are disclosed in WO 95/31945, the contents of which are incorporated herein in their entirety by reference.
Abstract
Medical devices may be made of shape-memory materials portions of which have been heat treated to exhibit spatial variations in the stiffness of the material. Devices including stents, vena cava filters and guidewires may be constructed from such materials. Devices may also be made from shape-memory materials which have been locally heat treated such that the superelasticity of the treated portion is destroyed while the remainder of the shape-memory material can transition between the martensitic and austenitic states.
Description
- The present invention is related to the use of shape memory materials in medical devices.
- A shape memory material can assume an initial high temperature configuration and a deformed low temperature configuration and revert back to the initial high temperature configuration upon the application of heat. The high temperature configuration of the material is set into the material or memorized during an initial shaping step in which the material is maintained at a high temperature in a desired shape for a period of time.
- This shape memory exhibited by metals results from the metal undergoing a reversible solid state phase transition. Specifically, the metal transitions from an austenitic state to a martensitic state with a decrease in temperature. The temperature at which the transition begins is typically designated Ms (martensite start temperature) while the temperature at which the transition finishes is designated Mf (martensite finish temperature). As the metal transitions from the austenitic state to the martensitic state it becomes more easily deformed. In the martensitic state, the metal is able to accommodate significant plastic deformation at an almost constant stress level.
- Upon heating a metal in the martensitic state, the metal begins to return to an austenitic state. The temperature at which this transition begins to occurs is designated As (Austenitic start temperature). The transition is complete at a temperature designated Af (Austenitic finish temperature). When Af is attained, the metal has fully reverted to its initial, high temperature configuration.
- Shape-memory materials have been disclosed in U.S. Pat. No. 3,012,882 to Muldawer et al. and U.S. Pat. No. 3,174,851 to Buehler et al. both of which are incorporated herein by reference in their entirety.
- A variety of materials exhibit shape memory properties including binary metals such as Nickel-Titanium alloys including Nitinol. Doped Nickel-Titanium alloys may also exhibit shape-memory properties.
- The use of shape-memory metals in medical applications has been disclosed in a number of references including U.S. Pat. No. 5,197,978 to Hess, U.S. Pat. No. 5,540,712 to Kleshinski et al., U.S. Pat. No. 5,597,378 to Jervis, U.S. Pat. No. 5,769,796 to Palermo et al., U.S. Pat. No. 5,846,247 to Unsworth et al. The contents of the above patents are incorporated herein in their entirety by reference.
- Shape-memory materials have been used, inter alia, in the production of stents. Nitinol stents which are fully expanded in the austenitic state and compressed or partially expanded in the martensitic state have been disclosed. The specific Nitinol alloy is chosen such that the stent will be in the austenitic state at body temperature. Prior to insertion into the body, the stent is maintained at low temperature corresponding to a temperature within the martensitic range. Upon delivery to a desired bodily location, the stent is warmed to at least the Af temperature and in the process expanded to its desired final diameter.
- Shape-memory metals have been disclosed for use in other medical devices as well.
- The physical properties, including elasticity and stiffness, of a shape-memory metal may be controlled via a variety of factors including the chemical composition of the alloy and the treatment to which the alloy is subjected. Commonly assigned U.S. patent application Ser. No. 09/008684, incorporated herein in its entirety by reference, discloses a process for improving the ductility of Nitinol via control of a number of process parameters. The physical properties of a shape-memory material may also be controlled by heat treating the material. By selective local heat treatment of a shape-memory material, it is possible to destroy the austenitic-martensitic transition and/or change the elasticity and stiffness.
- The present invention is directed to medical devices which use shape-memory materials that have been differentially heat treated to exhibit spatially varying properties such as elasticity and stiffness.
- The present invention is directed to medical devices having been formed, at least in part, from shape-memory materials which have been locally treated to alter their memory characteristics relative to portions of the device which have not been subjected to the local heat treatment. Specifically, a region of the shape-memory material is treated to decrease the stiffness of the region relative to the remainder of the medical device. Desirably, the local treatment will destroy the superelastic properties of the locally treated region.
- The invention is directed in particular to a stent having been formed at least in part of a shape-memory material. The stent comprises a plurality of cells arranged in columns extending from one end of the stent to the other. Adjacent columns of cells are interconnected. The stent includes at least one differently treated column of cells which has been treated differently from the remainder of the stent to have different shape-memory properties from the remainder of the stent.
- The invention is also directed to a stent wherein at least one of the columns is characterized by a reduced elasticity relative to the remainder of the columns.
- The invention is also directed to a stent wherein at least one of the columns is characterized by a reduced stiffness relative to the remainder of the columns.
- The invention is further directed to a stent wherein at a desired temperature range, at least one longitudinal column of cells does not have superelastic properties while the remainder of the longitudinal columns do have superelastic properties.
- The invention is also directed to a stent having been formed of a shape memory material and comprising a plurality of spaced segments. Adjacent spaced segments are connected to each other by one or more connector sections. Each segment comprises a series of interconnected cells. Desirably, the cells in plan view are of polygonal configuration. The segments have been subjected to a different heat treatment than the connector sections.
- The invention is also directed to a stent having been formed of a shape memory material and comprising a plurality of spaced segments with adjacent spaced segments connected to each other by one or more connector sections. Each segment comprises a series of interconnected cells. Desirably, the cells in plan view are of polygonal configuration. The segments have a reduced stiffness relative to the connector sections. Desirably, the segments are not superelastic.
- In another embodiment, the invention is directed to a medical guidewire having been formed at least in part of a shape-memory metal. Different portions of the shape-memory metal have been treated differently to have different shape-memory properties. Desirably, at least one portion of the guidewire is subjected to a local heat treatment resulting in a reduced stiffness compared with the remainder of the guidewire. In this way, a guidewire of desired flexibility can be prepared. Via the localized heat treatment, a guidewire may be prepared in which at least a portion thereof retains its shape memory properties while a portion thereof loses its shape memory properties.
- In yet another embodiment, the invention is directed to implantable medical filters such as vena cava filter having been formed of shape-memory materials. At least a portion of the shape-memory material is differently treated to alter the shape-memory properties of the material relative to the untreated shape-memory material. Desirably, the differently treated portion will be heat treated and exhibit a greater tendency toward plastic deformation relative to the remainder of the filter.
-
FIG. 1 illustrates the stress-strain behavior of an alloy which can undergo a transition from a martensitic state to an austenitic state and the stress-strain behavior of the alloy following additional heat treatment. -
FIG. 2 illustrates the stress-strain behavior of an alloy which can undergo a transition from a martensitic state to an austenitic state and the stress-strain behavior of the alloy following additional heat treatment. -
FIG. 3 a is a side-elevational view of a stent made in accordance with the present invention. -
FIG. 3 b is a side-elevational view of the stent ofFIG. 3 in which the treated column of cells has not been fully expanded. -
FIG. 4 a is a side elevational view of a stent made in accordance with the present invention. -
FIG. 4 b is a side elevational view of the stent ofFIG. 4 a after it has been bent. -
FIGS. 5 a and 5 b are views of embodiments of the invention in which connecting segments have been treated. -
FIG. 6 a shows a side elevational view of an inventive guidewire. -
FIG. 6 b shows the guidewire ofFIG. 6 a in a bent configuration. -
FIG. 6 c shows the guidewire ofFIG. 6 b after it has been released from the bent configuration. -
FIG. 6 d shows a side elevational view of an inventive guidewire whose distal tip has been treated to exhibit a reduced stiffness. -
FIG. 7 a shows a side elevational view of a prior art guidewire. -
FIG. 7 b shows the guidewire ofFIG. 7 a in a bent configuration. -
FIG. 7 c shows the guidewire ofFIG. 7 b after it has been released from the bent configuration. -
FIG. 8 shows a side elevational view of an inventive vena cava filter. - While this invention may be embodied in many different forms, there are described in detail herein specific preferred embodiments of the invention. This description is an exemplification of the principles of the invention and is not intended to limit the invention to the particular embodiments illustrated.
- The present invention is directed to the selective treatment of portions of a medical device containing a shape memory material. More specifically, the invention is directed to differential treatment of the shape memory material in a medical device to achieve different physical properties in different portions of the device.
- Medical devices made of a shape memory material such as Nitinol typically have shape memory characteristics. The shape memory characteristics of the material may be altered by heat treating the material. By locally treating portions of a shape-memory metal, it is possible to produce a metal with spatial variations in the elasticity and stiffness of the metal. The locally treated portions will initiate plastic deformation at a lower strain than the portions that have not been locally treated. Depending on the extent of the heat treatment, the material may simply have a reduced stiffness in the locally treated portion or the superelasticity of the locally treated portion may be destroyed with the locally treated portion being plastically deformable.
- In
FIG. 1 , a stress-strain curve (solid line) is shown for a shape-memory material. The stress-strain curve (dashed line) for the same material following additional heat treatment of the material is also shown. As a result of the heat treatment, the material has a reduced load and unload plateau, as shown inFIG. 1 and the material initiates plastic deformation at a lower strain level. - It has also been found that with sufficient heat treatment, the superelastic properties of the material may be destroyed. In
FIG. 2 , the stress-strain curve (solid line) is shown for a shape-memory material. The stress-strain curve (dashed line) for the same material following significant additional heat treatment to eliminate the superelastic properties of the material is also shown inFIG. 2 . - The shape memory material based medical device is typically subject to a first annealing using standard annealing processing conditions as are known in the art. Desirably, the device will be annealed for about 5 minutes to about 40 minutes at a temperature ranging from about 400 C to about 575 C. More desirably, the device will be annealed for about 10 minutes to about 15 minutes. Also more desirably, the device will be annealed at a temperature ranging from about 450 C to about 550 C. Shorter or longer periods may be used as may higher or lower temperatures, depending on the material being annealed and the desired properties of the material.
- Following the first annealing, the medical device is subjected to a second, localized, annealing step in which the device is heated further. The localized heat treatment of the desired shape-memory material medical device may be accomplished by any suitable method. One such suitable method involves the use of electrical resistance heating. Electrical leads are attached across the desired portion of the device and a current allowed to pass therethrough. Because of the resistance of the shape-memory metal, the desired portion of metal heats up thereby further annealing the material. The technique has been applied to a stent made of Nitinol wire (0.014 inch diameter). Leads were attached to a desired portion of the stent and 4 Volts applied to the wire. After 20 seconds, the desired portion of the wire transitioned from a superelastic state to a plastic state.
- Another suitable method involves applying a heated inert gas jet to a desired portion of the medical device to selectively heat a desired portion of the device. Yet another method involves the use of an induction coil. An induction coil may be placed over a desired portion of the medical device to effect induction heating of the desired portion of the medical device. A laser may also be used to selectively heat desired regions of the medical device. The desired regions of the medical device may also be brazed. The medical device may also be placed in a heat treating fluid such as a salt bath or a fluidized sand bath with appropriate sections of the device insulated.
- Regardless of the method chosen for the second annealing step, the second annealing step is typically carried out at a temperature of about 550 C to about 600 C for about five minutes to about 20 minutes. At such temperatures, the stiffness of the material will be reduced. As with the first annealing step, the exact time and temperature of the second annealing step depends on the material chosen (i.e. its composition) and on the form of the material (for example, in wire form or in sheet form). In certain cases, it may be desirable for the second annealing step to be carried out over shorter or longer periods of time and at lower or higher temperatures than those disclosed above. In one embodiment of the invention, it is desirable to locally heat treat the material during the second annealing step to destroy the shape memory feature of the metal in the treated region by treating the desired portions of the stent at temperatures of about 650 C to about 700 C and above. At temperatures of about 600 C to about 650 C, whether the heat treatment destroys the shape memory feature depends on the duration of the treatment and the composition of the material.
- The invention contemplates localized heat treating of a variety of medical devices including stents, medical guidewires and filters such as vena cava filters. For the purposes of this disclosure, it is understood that the term ‘stent’ is intended to include a variety of related devices including stents, grafts and stent-grafts in particular and endoluminal prostheses in general.
- In one embodiment, as shown in
FIG. 3 a, the invention is directed to a stent, shown generally at 100, comprised of a plurality ofcells 104 arranged incolumns 108 extending from one end 112 of the stent to the other end 116.Adjacent columns 108 ofcells 104 are interconnected. The stent includes at least one differently treatedcolumn 108 a ofcells 104 a which has been treated differently from the remainder ofcolumns 108 b to have different shape-memory properties from the remainder of the stent. - Desirably, differently treated
column 108 a will be characterized by an increased tendency to plastic deformation relative to the remainder of the stent and will be plastically deformable. More desirably, the superelasticity of the differently treated portion will be destroyed as a result of the heat treatment. - The invention also contemplates treating the column(s) such that the treated portion loses its shape memory characteristic.
-
FIG. 3 b shows the stent ofFIG. 3 a in a partially expanded state.Untreated columns 108 b are shown in an expanded state, having been exposed to a sufficient temperature to cause the metal to transition to its austenitic state.Treated column 108 a is in an unexpanded state, the superelastic properties of the material having been locally destroyed. - Although
columns 108 b are fully expanded,stent 100 may be further expanded by applying a radially outward force to the stent thereby opening or expanding treated column(s) 108 a. A balloon catheter or other expansion device may be used to effect such a ‘touch-up’ expansion of the stent. - By providing a column of cells of different shape memory properties which are not expanded in concert with the expansion of the remainder of the stent, the stent may later be ‘touched up’ via mechanical expansion of the cells of the treated column to better fit in a lumen.
- Another stent formed in accordance with the present invention is shown generally at 100 in
FIGS. 4 a and 4 b. One or more circumferential bands ofcells 122 is specially treated, in accordance with the invention.Bands 122 have different shape memory properties from the cells in the remainder of the stent. For example, band(s) 122 may be plastically deformable.FIG. 4 a depictsstent 100 prior to being deformed atband 122 whileFIG. 4 b depictsstent 100 after it has been bent atband 122. The remainder of the stent which has not been subjected to the special treatment retains the shape memory properties of the material. - The invention is also directed to the stent shown generally at 100 in
FIG. 5 a, comprised of a plurality of spacedsegments 120. Eachsegment 120 is desirably comprised of a series ofinterconnected cells 124. Desirably,cells 124 will be of polygonal configuration in plan view. More desirably, they will be hexagonal. Adjacent spacedsegments 120 are connected to each other by one ormore connector sections 128.Connector sections 128 may be disposed at an oblique angle relative to the longitudinal axis 180 of the stent as shown inFIG. 5 a or they may be substantially parallel to the longitudinal axis 180 as shown inFIG. 5 b. They may be straight or curved.Segments 120 have been subjected to a local heat treatment, in accordance with the invention. Desirably,segments 120 will be of lower stiffness thanconnector sections 128 as a result of the heat treatment. -
Stent 100 may be made of any suitable shape-memory material including shape-memory metals such as Nitinol. Nitinol with a composition of about 55.75% (by weight) nickel and 44.25% (by weight) titanium may be particularly well suited for use in the present invention. The stent may be made of shape-memory wire or a sheet or tube of shape-memory material. - The invention is also directed to stents similar to those shown in
FIGS. 5 a and 5 b, such as those disclosed in U.S. Ser. No. 08/942162 incorporated herein in its entirety by reference, wherein the connector sections and the segments are subject to different heat treatments. - The stent configurations of
FIGS. 3-5 are intended to be exemplary. Stents with other designs may be treated similarly. - In another embodiment, the invention is directed to medical guidewires made of shape-memory materials, portions of which have been differentially treated. In one aspect of the invention, a medical guidewire, such as that shown at 200 in
FIG. 6 a, is specially treated towarddistal end 204 of the guidewire.Region 208 of the device is heat treated to increase the tendency toward plastic deformation of the treated portion relative to the remainder of the guidewire. This, in turn, allows the guidewire to have a region of greater flexibility and a region of reduced flexibility corresponding to the locally treated section of the guidewire. -
FIGS. 6 b andFIG. 6 c illustrate the guidewire ofFIG. 6 a as it is bent and released. InFIG. 6 b, guidewire 200 is bent.Region 208 has a greater tendency toward plastic deformation. Theremainder 212 ofguidewire 200 is in the austenitic state and thus deforms elastically. The guidewire ofFIG. 6 b is shown inFIG. 6 c after it has been released from its bent position. Locally treatedregion 208 remains bent whileaustenitic regions 212 recovery fully to their configuration prior to being bent. Thus, by using Nitinol which has been treated to have spatially varying properties, it is possible to prepare a guidewire which may be permanently deformed within the body. - A local heat treatment may also be used to reduce the stiffness of the tip of the guidewire prior to inserting the guidewire into the body. This is illustrated schematically in
FIG. 6d .Distal end 204 ofguidewire 200 has been subject to an additional heat treatment to reduce the stiffness of the distal end relative to the remainder of the guidewire. If the superelasticity is completely destroyed, a permanent bend may be placed in the guidewire, thereby allowing a physician to shape a guide wire as desired. - For the sake of comparison, a fully austenitic guidewire is shown in various states in
FIGS. 7 a-c.FIG. 7 a shows guidewire 200. The entire guidewire is in theaustenitic state 212. In.FIG. 7 b, guidewire 200 is shown in a bent configuration. Asmall region 208 is in a stress-induced martensitic state while theremainder 212 ofguidewire 200 is in the austenitic phase. Upon release of the guidewire, as shown inFIG. 7 c, the entire guidewire returns to the configuration it had prior to being bent. The entire guidewire is in the austenitic state. - In yet another embodiment, the invention is directed to medical filters made, at least in part, of differentially treated shape-memory materials.
FIG. 8 shows a vena cava filter generally at 300.Vena cava filter 300 is similar in design to that disclosed in commonly assigned U.S. Pat. No. 5,709,704 to Nott et al., the content of which is incorporated herein in its entirety by reference.Filter 300 is constructed, at least in part, of a shape memory material.Filter 300 includes asingle cell 304 in which the shape-memory material is differentially heat treated to increase the tendency to plastic deformation of the desired portion of the filter. Although the filter ofFIG. 8 shows an embodiment in which only a single cell has been heat treated differently, the invention contemplates other embodiment in which a plurality of cells has been differently treated. One such variant involves a filter comprised of multiple columns of cells, one of the columns having been subjected to a different heat treatment. - The invention may be practiced generally with shape-memory materials. Desirably, binary shape-memory metals such as Nitinol or other alloys of Nickel and Titanium will be used. The invention also contemplates the use of doped binary metals as well. Suitable dopants include Chromium, Niobium and Vanadium. Additional suitable shape-memory alloys are disclosed in WO 95/31945, the contents of which are incorporated herein in their entirety by reference.
- The above disclosure is intended to be illustrative and not exhaustive. This description will suggest many variations and alternatives to one of ordinary skill in this art. All these alternatives and variations are intended to be included within the scope of the attached claims. Those familiar with the art may recognize other equivalents to the specific embodiments described herein which equivalents are also intended to be encompassed by the claims attached hereto.
Claims (11)
1-23. (canceled)
24. A medical guidewire having a proximal end and a distal end, the guidewire having been formed at least in part of a shape-memory metal and wherein different portions of the shape-memory metal have been treated differently to have different shape-memory properties.
25. The guidewire of claim 24 wherein different portions of the shape-memory metal are characterized by different stiffnesses.
26. The guidewire of claim 24 wherein the shape-memory metal includes a first portion and a second portion, the first and second portions having been annealed in a first annealing step at a first temperature, the second portion having been annealed for an additional period of time at a second temperature in excess of the first temperature.
27. The guidewire of claim 24 wherein the distal end of the guidewire has a lower stiffness than the proximal end of the guidewire.
28. The guidewire of claim 24 wherein at least a portion of a region extending from the distal end of the guidewire to about 50 cm from the distal end of the guidewire has a lower stiffness than adjacent regions of the guidewire.
29. The guidewire of claim 24 wherein a portion of the shape-memory metal has been heat treated to destroy the shape-memory properties of the portion.
30. The guidewire of claim 24 wherein the shape-memory metal is a Nickel-Titanium alloy.
31. The guidewire of claim 30 wherein the Nickel-Titanium alloy further comprises a dopant selected from the group consisting of Chromium, Niobium, Vanadium and combinations thereof.
32. A medical device formed at least in part of a shape-memory material wherein at least a first portion of the shape-memory material may transform between a martensitic state and an austenitic state and at least a second portion of the shape-memory material is incapable of transforming to the austenitic state at the same time as the first portion.
33. The medical device of claim 32 wherein the second portion has been heat treated to be incapable of transforming to the austenitic state.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/314,114 US20060100693A1 (en) | 1999-07-28 | 2005-12-20 | Multi-property nitinol by heart treatment |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/362,261 US6485507B1 (en) | 1999-07-28 | 1999-07-28 | Multi-property nitinol by heat treatment |
US10/304,249 US6997947B2 (en) | 1999-07-28 | 2002-11-26 | Multi-property nitinol by heat treatment |
US11/314,114 US20060100693A1 (en) | 1999-07-28 | 2005-12-20 | Multi-property nitinol by heart treatment |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/304,249 Division US6997947B2 (en) | 1999-07-28 | 2002-11-26 | Multi-property nitinol by heat treatment |
Publications (1)
Publication Number | Publication Date |
---|---|
US20060100693A1 true US20060100693A1 (en) | 2006-05-11 |
Family
ID=23425389
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/362,261 Expired - Lifetime US6485507B1 (en) | 1999-07-28 | 1999-07-28 | Multi-property nitinol by heat treatment |
US10/304,249 Expired - Fee Related US6997947B2 (en) | 1999-07-28 | 2002-11-26 | Multi-property nitinol by heat treatment |
US11/314,114 Abandoned US20060100693A1 (en) | 1999-07-28 | 2005-12-20 | Multi-property nitinol by heart treatment |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/362,261 Expired - Lifetime US6485507B1 (en) | 1999-07-28 | 1999-07-28 | Multi-property nitinol by heat treatment |
US10/304,249 Expired - Fee Related US6997947B2 (en) | 1999-07-28 | 2002-11-26 | Multi-property nitinol by heat treatment |
Country Status (9)
Country | Link |
---|---|
US (3) | US6485507B1 (en) |
EP (1) | EP1200014B1 (en) |
JP (1) | JP2003505194A (en) |
AT (1) | ATE342699T1 (en) |
AU (1) | AU5630900A (en) |
CA (1) | CA2378920C (en) |
DE (1) | DE60031413T2 (en) |
IL (1) | IL147727A0 (en) |
WO (1) | WO2001008600A2 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080077049A1 (en) * | 2006-08-24 | 2008-03-27 | Boston Scientific Scimed, Inc. | Elongate medical device including deformable distal end |
US20090062906A1 (en) * | 2005-05-23 | 2009-03-05 | Michihide Ozawa | Stent with autonomic function |
EP2684534A1 (en) * | 2012-07-12 | 2014-01-15 | Covidien LP | Heat-distribution indicators and electrosurgical systems including same |
US9439712B2 (en) | 2012-07-12 | 2016-09-13 | Covidien Lp | Heat-distribution indicators, thermal zone indicators, electrosurgical systems including same and methods of directing energy to tissue using same |
Families Citing this family (142)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6485507B1 (en) | 1999-07-28 | 2002-11-26 | Scimed Life Systems | Multi-property nitinol by heat treatment |
US6890350B1 (en) | 1999-07-28 | 2005-05-10 | Scimed Life Systems, Inc. | Combination self-expandable, balloon-expandable endoluminal device |
US7226475B2 (en) | 1999-11-09 | 2007-06-05 | Boston Scientific Scimed, Inc. | Stent with variable properties |
US6660021B1 (en) | 1999-12-23 | 2003-12-09 | Advanced Cardiovascular Systems, Inc. | Intravascular device and system |
US6402771B1 (en) | 1999-12-23 | 2002-06-11 | Guidant Endovascular Solutions | Snare |
US6575997B1 (en) | 1999-12-23 | 2003-06-10 | Endovascular Technologies, Inc. | Embolic basket |
US6695813B1 (en) | 1999-12-30 | 2004-02-24 | Advanced Cardiovascular Systems, Inc. | Embolic protection devices |
US7918820B2 (en) | 1999-12-30 | 2011-04-05 | Advanced Cardiovascular Systems, Inc. | Device for, and method of, blocking emboli in vessels such as blood arteries |
US6652576B1 (en) * | 2000-06-07 | 2003-11-25 | Advanced Cardiovascular Systems, Inc. | Variable stiffness stent |
US7632303B1 (en) | 2000-06-07 | 2009-12-15 | Advanced Cardiovascular Systems, Inc. | Variable stiffness medical devices |
US6964670B1 (en) | 2000-07-13 | 2005-11-15 | Advanced Cardiovascular Systems, Inc. | Embolic protection guide wire |
US7101391B2 (en) * | 2000-09-18 | 2006-09-05 | Inflow Dynamics Inc. | Primarily niobium stent |
US7402173B2 (en) * | 2000-09-18 | 2008-07-22 | Boston Scientific Scimed, Inc. | Metal stent with surface layer of noble metal oxide and method of fabrication |
ATE432673T1 (en) * | 2000-10-31 | 2009-06-15 | Boston Scient Ltd | ENDOLUMINAL DEVICE WITH SUPERELASTIC AND PLASTIC DEFORMABLE SECTIONS |
US8372139B2 (en) | 2001-02-14 | 2013-02-12 | Advanced Bio Prosthetic Surfaces, Ltd. | In vivo sensor and method of making same |
US6506203B1 (en) | 2000-12-19 | 2003-01-14 | Advanced Cardiovascular Systems, Inc. | Low profile sheathless embolic protection system |
US6585753B2 (en) | 2001-03-28 | 2003-07-01 | Scimed Life Systems, Inc. | Expandable coil stent |
US20050148925A1 (en) | 2001-04-20 | 2005-07-07 | Dan Rottenberg | Device and method for controlling in-vivo pressure |
AU2002256376B2 (en) * | 2001-04-26 | 2006-08-10 | Vascular Innovation, Inc. | Endoluminal device and method for fabricating same |
US7338510B2 (en) | 2001-06-29 | 2008-03-04 | Advanced Cardiovascular Systems, Inc. | Variable thickness embolic filtering devices and method of manufacturing the same |
US6599307B1 (en) | 2001-06-29 | 2003-07-29 | Advanced Cardiovascular Systems, Inc. | Filter device for embolic protection systems |
US6638294B1 (en) | 2001-08-30 | 2003-10-28 | Advanced Cardiovascular Systems, Inc. | Self furling umbrella frame for carotid filter |
US6592606B2 (en) | 2001-08-31 | 2003-07-15 | Advanced Cardiovascular Systems, Inc. | Hinged short cage for an embolic protection device |
US6796999B2 (en) | 2001-09-06 | 2004-09-28 | Medinol Ltd. | Self articulating stent |
US8262689B2 (en) | 2001-09-28 | 2012-09-11 | Advanced Cardiovascular Systems, Inc. | Embolic filtering devices |
ATE380001T1 (en) * | 2001-10-22 | 2007-12-15 | Terumo Corp | STENT AND METHOD FOR THE PRODUCTION THEREOF |
US6945994B2 (en) * | 2001-12-05 | 2005-09-20 | Boston Scientific Scimed, Inc. | Combined balloon-expanding and self-expanding stent |
US7241304B2 (en) | 2001-12-21 | 2007-07-10 | Advanced Cardiovascular Systems, Inc. | Flexible and conformable embolic filtering devices |
US7144420B2 (en) | 2002-03-14 | 2006-12-05 | Boston Scientific Scimed, Inc. | Segmented spine |
WO2003082076A2 (en) | 2002-03-25 | 2003-10-09 | Nmt Medical, Inc. | Patent foramen ovale (pfo) closure clips |
US20030187495A1 (en) * | 2002-04-01 | 2003-10-02 | Cully Edward H. | Endoluminal devices, embolic filters, methods of manufacture and use |
WO2003094692A2 (en) * | 2002-05-14 | 2003-11-20 | The University Of Hong Kong | Supreme distracter |
AU2003253620A1 (en) | 2002-06-03 | 2003-12-19 | Nmt Medical, Inc. | Device with biological tissue scaffold for intracardiac defect closure |
JP2005528181A (en) | 2002-06-05 | 2005-09-22 | エヌエムティー メディカル インコーポレイテッド | Patent foramen ovale (PFO) occlusion device with radial and circumferential supports |
CA2494702A1 (en) * | 2002-08-02 | 2004-02-12 | Auxetica Limited | Auxetic tubular liners |
US7252675B2 (en) | 2002-09-30 | 2007-08-07 | Advanced Cardiovascular, Inc. | Embolic filtering devices |
US7331973B2 (en) | 2002-09-30 | 2008-02-19 | Avdanced Cardiovascular Systems, Inc. | Guide wire with embolic filtering attachment |
US7976936B2 (en) | 2002-10-11 | 2011-07-12 | University Of Connecticut | Endoprostheses |
US7794494B2 (en) | 2002-10-11 | 2010-09-14 | Boston Scientific Scimed, Inc. | Implantable medical devices |
US7731744B1 (en) * | 2002-10-25 | 2010-06-08 | Advanced Cariovascular Systems, Inc. | Intravascular stent for treating vulnerable plaque and method of use |
US20040088000A1 (en) | 2002-10-31 | 2004-05-06 | Muller Paul F. | Single-wire expandable cages for embolic filtering devices |
CA2503349A1 (en) * | 2002-11-06 | 2004-05-27 | Nmt Medical, Inc. | Medical devices utilizing modified shape memory alloy |
US6923829B2 (en) | 2002-11-25 | 2005-08-02 | Advanced Bio Prosthetic Surfaces, Ltd. | Implantable expandable medical devices having regions of differential mechanical properties and methods of making same |
CA2503666A1 (en) | 2002-12-09 | 2004-06-24 | Nmt Medical, Inc. | Septal closure devices |
US7172624B2 (en) | 2003-02-06 | 2007-02-06 | Boston Scientific Scimed, Inc. | Medical device with magnetic resonance visibility enhancing structure |
US7025779B2 (en) * | 2003-02-26 | 2006-04-11 | Scimed Life Systems, Inc. | Endoluminal device having enhanced affixation characteristics |
US8591540B2 (en) | 2003-02-27 | 2013-11-26 | Abbott Cardiovascular Systems Inc. | Embolic filtering devices |
US9861346B2 (en) | 2003-07-14 | 2018-01-09 | W. L. Gore & Associates, Inc. | Patent foramen ovale (PFO) closure device with linearly elongating petals |
US8480706B2 (en) | 2003-07-14 | 2013-07-09 | W.L. Gore & Associates, Inc. | Tubular patent foramen ovale (PFO) closure device with catch system |
EP1651116B1 (en) | 2003-07-14 | 2013-06-26 | W.L. Gore & Associates, Inc. | Tubular patent foramen ovale (pfo) closure device with catch system |
US7479157B2 (en) | 2003-08-07 | 2009-01-20 | Boston Scientific Scimed, Inc. | Stent designs which enable the visibility of the inside of the stent during MRI |
US7455737B2 (en) * | 2003-08-25 | 2008-11-25 | Boston Scientific Scimed, Inc. | Selective treatment of linear elastic materials to produce localized areas of superelasticity |
US8333798B2 (en) | 2003-11-07 | 2012-12-18 | Merlin Md Pte Ltd. | Implantable medical devices with enhanced visibility, mechanical properties and biocompatability |
US7892251B1 (en) | 2003-11-12 | 2011-02-22 | Advanced Cardiovascular Systems, Inc. | Component for delivering and locking a medical device to a guide wire |
US20050149168A1 (en) * | 2003-12-30 | 2005-07-07 | Daniel Gregorich | Stent to be deployed on a bend |
US7871419B2 (en) | 2004-03-03 | 2011-01-18 | Nmt Medical, Inc. | Delivery/recovery system for septal occluder |
JP4351560B2 (en) * | 2004-03-05 | 2009-10-28 | Necトーキン株式会社 | Balloon expandable superelastic stent |
US7678129B1 (en) | 2004-03-19 | 2010-03-16 | Advanced Cardiovascular Systems, Inc. | Locking component for an embolic filter assembly |
EP1734897A4 (en) | 2004-03-31 | 2010-12-22 | Merlin Md Pte Ltd | A method for treating aneurysms |
US8715340B2 (en) | 2004-03-31 | 2014-05-06 | Merlin Md Pte Ltd. | Endovascular device with membrane |
US8500751B2 (en) | 2004-03-31 | 2013-08-06 | Merlin Md Pte Ltd | Medical device |
EP1600121B1 (en) * | 2004-05-25 | 2007-07-18 | William Cook Europe ApS | Stent and stent retrieval system |
US8062033B2 (en) | 2004-06-08 | 2011-11-22 | Gold Standard Instruments, LLC | Dental and medical instruments comprising titanium |
US20050278017A1 (en) | 2004-06-09 | 2005-12-15 | Scimed Life Systems, Inc. | Overlapped stents for scaffolding, flexibility and MRI compatibility |
US7896222B2 (en) * | 2004-10-01 | 2011-03-01 | Regents Of The University Of Michigan | Manufacture of shape memory alloy cellular materials and structures by transient-liquid reactive joining |
US7344560B2 (en) | 2004-10-08 | 2008-03-18 | Boston Scientific Scimed, Inc. | Medical devices and methods of making the same |
US8043361B2 (en) | 2004-12-10 | 2011-10-25 | Boston Scientific Scimed, Inc. | Implantable medical devices, and methods of delivering the same |
US8435280B2 (en) * | 2005-03-31 | 2013-05-07 | Boston Scientific Scimed, Inc. | Flexible stent with variable width elements |
US9259305B2 (en) | 2005-03-31 | 2016-02-16 | Abbott Cardiovascular Systems Inc. | Guide wire locking mechanism for rapid exchange and other catheter systems |
ES2764992T3 (en) | 2005-04-04 | 2020-06-05 | Flexible Stenting Solutions Inc | Flexible stent |
JP4737518B2 (en) * | 2005-05-23 | 2011-08-03 | Necトーキン株式会社 | Ti-Ni-Nb alloy element |
US7627382B2 (en) * | 2005-05-25 | 2009-12-01 | Lake Region Manufacturing, Inc. | Medical devices with aromatic polyimide coating |
US8292946B2 (en) * | 2005-10-25 | 2012-10-23 | Boston Scientific Scimed, Inc. | Medical implants with limited resistance to migration |
WO2007083288A2 (en) | 2006-01-23 | 2007-07-26 | Atria Medical Inc. | Heart anchor device |
US8348991B2 (en) | 2006-03-29 | 2013-01-08 | Boston Scientific Scimed, Inc. | Stent with overlap and high expansion |
EP3067436B1 (en) * | 2006-06-16 | 2019-11-06 | Covidien LP | Implant having high fatigue resistance, delivery system, and method of use |
US7780798B2 (en) | 2006-10-13 | 2010-08-24 | Boston Scientific Scimed, Inc. | Medical devices including hardened alloys |
WO2008124603A1 (en) | 2007-04-05 | 2008-10-16 | Nmt Medical, Inc. | Septal closure device with centering mechanism |
US9138562B2 (en) | 2007-04-18 | 2015-09-22 | W.L. Gore & Associates, Inc. | Flexible catheter system |
US8211162B2 (en) * | 2007-05-25 | 2012-07-03 | Boston Scientific Scimed, Inc. | Connector node for durable stent |
US8216209B2 (en) | 2007-05-31 | 2012-07-10 | Abbott Cardiovascular Systems Inc. | Method and apparatus for delivering an agent to a kidney |
US7867273B2 (en) | 2007-06-27 | 2011-01-11 | Abbott Laboratories | Endoprostheses for peripheral arteries and other body vessels |
US7988723B2 (en) | 2007-08-02 | 2011-08-02 | Flexible Stenting Solutions, Inc. | Flexible stent |
US8066755B2 (en) | 2007-09-26 | 2011-11-29 | Trivascular, Inc. | System and method of pivoted stent deployment |
US8663309B2 (en) | 2007-09-26 | 2014-03-04 | Trivascular, Inc. | Asymmetric stent apparatus and method |
US8226701B2 (en) | 2007-09-26 | 2012-07-24 | Trivascular, Inc. | Stent and delivery system for deployment thereof |
EP2194921B1 (en) | 2007-10-04 | 2018-08-29 | TriVascular, Inc. | Modular vascular graft for low profile percutaneous delivery |
DE102007050666A1 (en) * | 2007-10-24 | 2009-04-30 | Biotronik Vi Patent Ag | Nitinol stent with improved axial flexural rigidity and associated manufacturing process |
US8328861B2 (en) | 2007-11-16 | 2012-12-11 | Trivascular, Inc. | Delivery system and method for bifurcated graft |
US8083789B2 (en) | 2007-11-16 | 2011-12-27 | Trivascular, Inc. | Securement assembly and method for expandable endovascular device |
US8128677B2 (en) | 2007-12-12 | 2012-03-06 | Intact Vascular LLC | Device and method for tacking plaque to a blood vessel wall |
US20130165967A1 (en) | 2008-03-07 | 2013-06-27 | W.L. Gore & Associates, Inc. | Heart occlusion devices |
US8262692B2 (en) | 2008-09-05 | 2012-09-11 | Merlin Md Pte Ltd | Endovascular device |
US9149376B2 (en) | 2008-10-06 | 2015-10-06 | Cordis Corporation | Reconstrainable stent delivery system |
GB2468861B (en) * | 2009-03-23 | 2011-05-18 | Cook William Europ | Conformable stent structure and method of making same |
US20210161637A1 (en) | 2009-05-04 | 2021-06-03 | V-Wave Ltd. | Shunt for redistributing atrial blood volume |
US20120029556A1 (en) | 2009-06-22 | 2012-02-02 | Masters Steven J | Sealing device and delivery system |
US8956389B2 (en) | 2009-06-22 | 2015-02-17 | W. L. Gore & Associates, Inc. | Sealing device and delivery system |
US20110022026A1 (en) | 2009-07-21 | 2011-01-27 | Lake Region Manufacturing, Inc. d/b/a Lake Region Medical. Inc. | Methods and Devices for Delivering Drugs Using Drug-Delivery or Drug-Coated Guidewires |
CN102665891B (en) | 2009-08-07 | 2015-11-25 | 创新加工技术有限公司 | For the treatment of the method and system of material comprising shape-memory material |
GB2476479B (en) * | 2009-12-22 | 2012-06-20 | Cook Medical Technologies Llc | Implantable device |
US8361140B2 (en) * | 2009-12-29 | 2013-01-29 | Boston Scientific Scimed, Inc. | High strength low opening pressure stent design |
US8382834B2 (en) | 2010-04-12 | 2013-02-26 | Enteroptyx | Induction heater system for shape memory medical implants and method of activating shape memory medical implants within the mammalian body |
US20120209338A1 (en) | 2011-02-10 | 2012-08-16 | Jorge Groiso | Device for correction of bone and soft tissue disorders |
JP6235345B2 (en) | 2011-03-08 | 2017-11-22 | ダブリュ.エル.ゴア アンド アソシエイツ,インコーポレイティドW.L. Gore & Associates, Incorporated | Medical device for use with stoma |
US11135054B2 (en) | 2011-07-28 | 2021-10-05 | V-Wave Ltd. | Interatrial shunts having biodegradable material, and methods of making and using same |
US9770232B2 (en) | 2011-08-12 | 2017-09-26 | W. L. Gore & Associates, Inc. | Heart occlusion devices |
FR2981260B1 (en) | 2011-10-18 | 2014-12-12 | Univ Grenoble 1 | DEVICE FOR GUIDING A MEDICAL NEEDLE |
JP6069348B2 (en) * | 2011-12-16 | 2017-02-01 | ストライカー コーポレイションStryker Corporation | Embolization removal cage |
US8894701B2 (en) | 2011-12-23 | 2014-11-25 | Cook Medical Technologies Llc | Hybrid balloon-expandable/self-expanding prosthesis for deployment in a body vessel and method of making |
US8992595B2 (en) | 2012-04-04 | 2015-03-31 | Trivascular, Inc. | Durable stent graft with tapered struts and stable delivery methods and devices |
EP2833837B1 (en) | 2012-04-06 | 2023-03-29 | Merlin MD PTE Ltd. | Devices for treating an aneurysm |
US9498363B2 (en) | 2012-04-06 | 2016-11-22 | Trivascular, Inc. | Delivery catheter for endovascular device |
US20140094861A1 (en) * | 2012-10-01 | 2014-04-03 | Smith & Nephew, Inc. | Surgical locator |
US10828019B2 (en) | 2013-01-18 | 2020-11-10 | W.L. Gore & Associates, Inc. | Sealing device and delivery system |
EP2999412B1 (en) | 2013-05-21 | 2020-05-06 | V-Wave Ltd. | Apparatus for delivering devices for reducing left atrial pressure |
US20150250574A1 (en) * | 2014-03-07 | 2015-09-10 | Novus Scientific Ab | Support device used in medical breast reconstruction |
US11439396B2 (en) | 2014-05-02 | 2022-09-13 | W. L. Gore & Associates, Inc. | Occluder and anastomosis devices |
US10004509B2 (en) | 2014-05-02 | 2018-06-26 | W. L. Gore & Associates, Inc. | Anastomosis devices |
US11712230B2 (en) | 2014-05-02 | 2023-08-01 | W. L. Gore & Associates, Inc. | Occluder and anastomosis devices |
US9808230B2 (en) | 2014-06-06 | 2017-11-07 | W. L. Gore & Associates, Inc. | Sealing device and delivery system |
US9375336B1 (en) | 2015-01-29 | 2016-06-28 | Intact Vascular, Inc. | Delivery device and method of delivery |
US9433520B2 (en) | 2015-01-29 | 2016-09-06 | Intact Vascular, Inc. | Delivery device and method of delivery |
EP3291773A4 (en) | 2015-05-07 | 2019-05-01 | The Medical Research, Infrastructure, And Health Services Fund Of The Tel Aviv Medical Center | Temporary interatrial shunts |
EP3294160B1 (en) | 2015-05-14 | 2022-04-20 | Cook Medical Technologies, LLC | Endoscopic needle stylet with enhanced-flexibility lengths |
US10993824B2 (en) | 2016-01-01 | 2021-05-04 | Intact Vascular, Inc. | Delivery device and method of delivery |
US10835394B2 (en) | 2016-05-31 | 2020-11-17 | V-Wave, Ltd. | Systems and methods for making encapsulated hourglass shaped stents |
US20170340460A1 (en) | 2016-05-31 | 2017-11-30 | V-Wave Ltd. | Systems and methods for making encapsulated hourglass shaped stents |
US10932685B2 (en) * | 2017-01-09 | 2021-03-02 | Biosense Webster (Israel) Ltd. | Catheter with supporting structure having variable dimensions |
AU2018228451B2 (en) | 2017-03-03 | 2022-12-08 | V-Wave Ltd. | Shunt for redistributing atrial blood volume |
US11291807B2 (en) | 2017-03-03 | 2022-04-05 | V-Wave Ltd. | Asymmetric shunt for redistributing atrial blood volume |
US11724075B2 (en) | 2017-04-18 | 2023-08-15 | W. L. Gore & Associates, Inc. | Deployment constraining sheath that enables staged deployment by device section |
US11660218B2 (en) | 2017-07-26 | 2023-05-30 | Intact Vascular, Inc. | Delivery device and method of delivery |
US11458287B2 (en) | 2018-01-20 | 2022-10-04 | V-Wave Ltd. | Devices with dimensions that can be reduced and increased in vivo, and methods of making and using the same |
US10898698B1 (en) * | 2020-05-04 | 2021-01-26 | V-Wave Ltd. | Devices with dimensions that can be reduced and increased in vivo, and methods of making and using the same |
WO2019142152A1 (en) | 2018-01-20 | 2019-07-25 | V-Wave Ltd. | Devices and methods for providing passage between heart chambers |
JP7260525B2 (en) * | 2018-03-27 | 2023-04-18 | テルモ株式会社 | stent |
US11291570B2 (en) | 2018-04-27 | 2022-04-05 | Cook Medical Technologies Llc | Hybrid stent and delivery system |
US11612385B2 (en) | 2019-04-03 | 2023-03-28 | V-Wave Ltd. | Systems and methods for delivering implantable devices across an atrial septum |
WO2020234751A1 (en) | 2019-05-20 | 2020-11-26 | V-Wave Ltd. | Systems and methods for creating an interatrial shunt |
US11234702B1 (en) | 2020-11-13 | 2022-02-01 | V-Wave Ltd. | Interatrial shunt having physiologic sensor |
WO2023199267A1 (en) | 2022-04-14 | 2023-10-19 | V-Wave Ltd. | Interatrial shunt with expanded neck region |
Citations (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3012332A (en) * | 1959-04-16 | 1961-12-12 | Gen Electric | Heat storage reservoir for clothes dryer |
US3174851A (en) * | 1961-12-01 | 1965-03-23 | William J Buehler | Nickel-base alloys |
US5069226A (en) * | 1989-04-28 | 1991-12-03 | Tokin Corporation | Catheter guidewire with pseudo elastic shape memory alloy |
US5104404A (en) * | 1989-10-02 | 1992-04-14 | Medtronic, Inc. | Articulated stent |
US5171383A (en) * | 1987-01-07 | 1992-12-15 | Terumo Kabushiki Kaisha | Method of manufacturing a differentially heat treated catheter guide wire |
US5197978A (en) * | 1991-04-26 | 1993-03-30 | Advanced Coronary Technology, Inc. | Removable heat-recoverable tissue supporting device |
US5383892A (en) * | 1991-11-08 | 1995-01-24 | Meadox France | Stent for transluminal implantation |
US5540712A (en) * | 1992-05-01 | 1996-07-30 | Nitinol Medical Technologies, Inc. | Stent and method and apparatus for forming and delivering the same |
US5597378A (en) * | 1983-10-14 | 1997-01-28 | Raychem Corporation | Medical devices incorporating SIM alloy elements |
US5709704A (en) * | 1994-11-30 | 1998-01-20 | Boston Scientific Corporation | Blood clot filtering |
US5769796A (en) * | 1993-05-11 | 1998-06-23 | Target Therapeutics, Inc. | Super-elastic composite guidewire |
US5776100A (en) * | 1995-09-27 | 1998-07-07 | Interventional Innovations Corporation | Nickel titanium guide wires for occlusion and drug delivery |
US5807404A (en) * | 1996-09-19 | 1998-09-15 | Medinol Ltd. | Stent with variable features to optimize support and method of making such stent |
US5836893A (en) * | 1996-03-08 | 1998-11-17 | Scimed Life Systems, Inc. | Intravascular guidewire |
US5843244A (en) * | 1996-06-13 | 1998-12-01 | Nitinol Devices And Components | Shape memory alloy treatment |
US5846247A (en) * | 1996-11-15 | 1998-12-08 | Unsworth; John D. | Shape memory tubular deployment system |
US5868783A (en) * | 1997-04-16 | 1999-02-09 | Numed, Inc. | Intravascular stent with limited axial shrinkage |
US5938697A (en) * | 1998-03-04 | 1999-08-17 | Scimed Life Systems, Inc. | Stent having variable properties |
US6217567B1 (en) * | 1997-03-06 | 2001-04-17 | Percusurge, Inc. | Hollow medical wires and methods of constructing same |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3012882A (en) | 1960-01-26 | 1961-12-12 | Muldawer Leonard | Temperature responsive cadmium-silver-gold alloys |
EP0746236B1 (en) | 1993-10-01 | 2003-08-20 | Boston Scientific Corporation | Improved vena cava filter |
ES2126896T3 (en) | 1994-05-19 | 1999-04-01 | Scimed Life Systems Inc | IMPROVED BIOLOGICAL TISSUE SUPPORT DEVICES. |
US5868780A (en) | 1996-03-22 | 1999-02-09 | Lashinski; Robert D. | Stents for supporting lumens in living tissue |
US5931819A (en) | 1996-04-18 | 1999-08-03 | Advanced Cardiovascular Systems, Inc. | Guidewire with a variable stiffness distal portion |
DE19633901A1 (en) | 1996-08-22 | 1998-02-26 | Thomas Prof Dr Med Ischinger | Vascular support in the form of a tube section-like support structure |
US5924998A (en) | 1997-03-06 | 1999-07-20 | Scimed Life System, Inc. | Guide wire with hydrophilically coated tip |
US5853419A (en) * | 1997-03-17 | 1998-12-29 | Surface Genesis, Inc. | Stent |
US6425855B2 (en) * | 1999-04-06 | 2002-07-30 | Cordis Corporation | Method for making a multi-laminate stent having superelastic articulated sections |
US6485507B1 (en) | 1999-07-28 | 2002-11-26 | Scimed Life Systems | Multi-property nitinol by heat treatment |
US6585753B2 (en) * | 2001-03-28 | 2003-07-01 | Scimed Life Systems, Inc. | Expandable coil stent |
-
1999
- 1999-07-28 US US09/362,261 patent/US6485507B1/en not_active Expired - Lifetime
-
2000
- 2000-06-22 CA CA002378920A patent/CA2378920C/en not_active Expired - Fee Related
- 2000-06-22 DE DE60031413T patent/DE60031413T2/en not_active Expired - Lifetime
- 2000-06-22 IL IL14772700A patent/IL147727A0/en unknown
- 2000-06-22 AU AU56309/00A patent/AU5630900A/en not_active Abandoned
- 2000-06-22 AT AT00941621T patent/ATE342699T1/en not_active IP Right Cessation
- 2000-06-22 EP EP00941621A patent/EP1200014B1/en not_active Expired - Lifetime
- 2000-06-22 WO PCT/US2000/017116 patent/WO2001008600A2/en active IP Right Grant
- 2000-06-22 JP JP2001513337A patent/JP2003505194A/en active Pending
-
2002
- 2002-11-26 US US10/304,249 patent/US6997947B2/en not_active Expired - Fee Related
-
2005
- 2005-12-20 US US11/314,114 patent/US20060100693A1/en not_active Abandoned
Patent Citations (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3012332A (en) * | 1959-04-16 | 1961-12-12 | Gen Electric | Heat storage reservoir for clothes dryer |
US3174851A (en) * | 1961-12-01 | 1965-03-23 | William J Buehler | Nickel-base alloys |
US5597378A (en) * | 1983-10-14 | 1997-01-28 | Raychem Corporation | Medical devices incorporating SIM alloy elements |
US5171383A (en) * | 1987-01-07 | 1992-12-15 | Terumo Kabushiki Kaisha | Method of manufacturing a differentially heat treated catheter guide wire |
US5069226A (en) * | 1989-04-28 | 1991-12-03 | Tokin Corporation | Catheter guidewire with pseudo elastic shape memory alloy |
US5104404A (en) * | 1989-10-02 | 1992-04-14 | Medtronic, Inc. | Articulated stent |
US5197978A (en) * | 1991-04-26 | 1993-03-30 | Advanced Coronary Technology, Inc. | Removable heat-recoverable tissue supporting device |
US5197978B1 (en) * | 1991-04-26 | 1996-05-28 | Advanced Coronary Tech | Removable heat-recoverable tissue supporting device |
US5383892A (en) * | 1991-11-08 | 1995-01-24 | Meadox France | Stent for transluminal implantation |
US5540712A (en) * | 1992-05-01 | 1996-07-30 | Nitinol Medical Technologies, Inc. | Stent and method and apparatus for forming and delivering the same |
US5769796A (en) * | 1993-05-11 | 1998-06-23 | Target Therapeutics, Inc. | Super-elastic composite guidewire |
US5902317A (en) * | 1994-06-01 | 1999-05-11 | Nitinol Medical Technologies, Inc. | Stent and method and apparatus for forming and delivering the same |
US5709704A (en) * | 1994-11-30 | 1998-01-20 | Boston Scientific Corporation | Blood clot filtering |
US5776100A (en) * | 1995-09-27 | 1998-07-07 | Interventional Innovations Corporation | Nickel titanium guide wires for occlusion and drug delivery |
US5836893A (en) * | 1996-03-08 | 1998-11-17 | Scimed Life Systems, Inc. | Intravascular guidewire |
US5843244A (en) * | 1996-06-13 | 1998-12-01 | Nitinol Devices And Components | Shape memory alloy treatment |
US5807404A (en) * | 1996-09-19 | 1998-09-15 | Medinol Ltd. | Stent with variable features to optimize support and method of making such stent |
US5846247A (en) * | 1996-11-15 | 1998-12-08 | Unsworth; John D. | Shape memory tubular deployment system |
US6217567B1 (en) * | 1997-03-06 | 2001-04-17 | Percusurge, Inc. | Hollow medical wires and methods of constructing same |
US5868783A (en) * | 1997-04-16 | 1999-02-09 | Numed, Inc. | Intravascular stent with limited axial shrinkage |
US5938697A (en) * | 1998-03-04 | 1999-08-17 | Scimed Life Systems, Inc. | Stent having variable properties |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090062906A1 (en) * | 2005-05-23 | 2009-03-05 | Michihide Ozawa | Stent with autonomic function |
US8652199B2 (en) * | 2005-05-23 | 2014-02-18 | Nec Tokin Corporation | Stent with autonomic function |
US20080077049A1 (en) * | 2006-08-24 | 2008-03-27 | Boston Scientific Scimed, Inc. | Elongate medical device including deformable distal end |
US8728010B2 (en) * | 2006-08-24 | 2014-05-20 | Boston Scientific Scimed, Inc. | Elongate medical device including deformable distal end |
EP2684534A1 (en) * | 2012-07-12 | 2014-01-15 | Covidien LP | Heat-distribution indicators and electrosurgical systems including same |
US9439712B2 (en) | 2012-07-12 | 2016-09-13 | Covidien Lp | Heat-distribution indicators, thermal zone indicators, electrosurgical systems including same and methods of directing energy to tissue using same |
Also Published As
Publication number | Publication date |
---|---|
JP2003505194A (en) | 2003-02-12 |
CA2378920A1 (en) | 2001-02-08 |
IL147727A0 (en) | 2002-08-14 |
CA2378920C (en) | 2009-01-13 |
WO2001008600A2 (en) | 2001-02-08 |
ATE342699T1 (en) | 2006-11-15 |
DE60031413T2 (en) | 2007-09-20 |
US6485507B1 (en) | 2002-11-26 |
DE60031413D1 (en) | 2006-11-30 |
US20030109918A1 (en) | 2003-06-12 |
US6997947B2 (en) | 2006-02-14 |
EP1200014B1 (en) | 2006-10-18 |
EP1200014A2 (en) | 2002-05-02 |
WO2001008600A3 (en) | 2001-07-05 |
AU5630900A (en) | 2001-02-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6485507B1 (en) | Multi-property nitinol by heat treatment | |
US7632303B1 (en) | Variable stiffness medical devices | |
CA2467940C (en) | Improved radiopacity intraluminal medical device | |
JP4046760B2 (en) | Improved tissue support device | |
US6325824B2 (en) | Crush resistant stent | |
US8974517B2 (en) | Thermoelastic and superelastic NI-TI-W alloy | |
EP1365830B1 (en) | Total occlusion guidewire device | |
EP1356789B1 (en) | Intraluminal medical device with radiopaque markers | |
US6572646B1 (en) | Curved nitinol stent for extremely tortuous anatomy | |
US20070239259A1 (en) | Nitinol alloy design and composition for medical devices | |
US6440162B1 (en) | Stent having increased scaffolding expandable bar arms | |
US20110152994A1 (en) | Implantable device | |
EP2410956B1 (en) | Conformable stent structure and method of making same | |
JP2004501680A (en) | Stent with different stiffness | |
EP1663329A1 (en) | Fatigue resistant medical devices | |
JP2004520883A (en) | Radiopaque nitinol alloy for medical devices | |
EP1545679B1 (en) | Radiopaque nitinol alloys for medical devices | |
JP2005506112A (en) | Intraluminal device and method of making the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: BOSTON SCIENTIFIC SCIMED, INC., MINNESOTA Free format text: CHANGE OF NAME;ASSIGNOR:SCIMED LIFE SYSTEMS, INC.;REEL/FRAME:018505/0868 Effective date: 20050101 Owner name: BOSTON SCIENTIFIC SCIMED, INC.,MINNESOTA Free format text: CHANGE OF NAME;ASSIGNOR:SCIMED LIFE SYSTEMS, INC.;REEL/FRAME:018505/0868 Effective date: 20050101 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |